Figures computed from official regulatory filings — .
Analysttarget 11 USD (+54%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 25.34% · institutions 28.44% · short 3.8% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Neuraxis, INC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
4 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Carrico Brian Allen | Award | n/a (No price was disclosed in the filing) | SEC |
| Carrico Thomas Joeseph | Award | n/a (No price was disclosed in the filing) | SEC |
| Carrico Thomas Joeseph | OtherD (derivative) | $2.1M | SEC |
| Carrico Brian Allen | OtherD (derivative) | $2.2M | SEC |
| Miranda Adrian | Award | n/a (No price was disclosed in the filing) | SEC |
| Carrico Brian Allen | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Carrico Brian Allen | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Miranda Adrian | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Carrico Thomas Joeseph | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Carrico Thomas Joeseph | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Miranda Adrian | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Miranda Adrian | OtherD (derivative) | $2.3M | SEC |
| Aharon Giltrack record | Award | $275.9K | Unusual size | SEC |
| Carrico Thomas Joeseph | AwardD (derivative) | $853.5K | Unusual size | SEC |
| Miranda Adrian | AwardD (derivative) | $837.4K | Unusual size | SEC |
| Keyser Jane Elizabeth | Award | $163.7K | Unusual size | SEC |
| Watkins Bradley Mitchell | Award | $163.7K | Unusual size | SEC |
| Henrichs Timothy Robert | AwardD (derivative) | $888.5K | Unusual size | SEC |
| Aharon Giltrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Carrico Brian Allen | AwardD (derivative) | $1.2M | Unusual size | SEC |
| Aharon Giltrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Ferge Kristin A | Award | $195.5K | Unusual size | SEC |
| Aharon Giltrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Aharon Giltrack record | Award | n/a (No price was disclosed in the filing) | SEC |
| Carrico Brian Allen | Buy | $15.8K | conv 50ClusterFirst in 12mo | SEC |